These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38369283)

  • 1. Development and Valuation of a Preference-Weighted Measure in Age-Related Macular Degeneration From the Vision Impairment in Low Luminance Questionnaire: A MACUSTAR Report.
    Rowen D; Carlton J; Terheyden JH; Finger RP; Wickramasekera N; Brazier J;
    Value Health; 2024 May; 27(5):642-654. PubMed ID: 38369283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration - a MACUSTAR study report.
    Terheyden JH; Pondorfer SG; Behning C; Berger M; Carlton J; Rowen D; Bouchet C; Poor S; Luhmann UFO; Leal S; Holz FG; Butt T; Brazier JE; Finger RP;
    Br J Ophthalmol; 2023 Aug; 107(8):1144-1150. PubMed ID: 35354561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the Vision Impairment in Low Luminance Questionnaire.
    Pondorfer SG; Terheyden JH; Overhoff H; Stasch-Bouws J; Holz FG; Finger RP
    Transl Vis Sci Technol; 2021 Jan; 10(1):5. PubMed ID: 33505772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Vision-related Quality of Life with Visual Function in Age-Related Macular Degeneration.
    Pondorfer SG; Terheyden JH; Heinemann M; Wintergerst MWM; Holz FG; Finger RP
    Sci Rep; 2019 Oct; 9(1):15326. PubMed ID: 31653904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating a Preference-Based Index for Mental Health From the Recovering Quality of Life Measure: Valuation of Recovering Quality of Life Utility Index.
    Keetharuth AD; Rowen D; Bjorner JB; Brazier J
    Value Health; 2021 Feb; 24(2):281-290. PubMed ID: 33518035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and public preferences for health states associated with AMD.
    Butt T; Dunbar HM; Morris S; Orr S; Rubin GS
    Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation of a UK preference-based value set for the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS) to allow estimation of Mental Well-being Adjusted Life Years (MWALYs).
    Yiu HHE; Buckell J; Petrou S; Stewart-Brown S; Madan J
    Soc Sci Med; 2023 Jun; 327():115928. PubMed ID: 37201343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular Degeneration.
    Danner M; Vennedey V; Hiligsmann M; Fauser S; Gross C; Stock S
    Value Health; 2017 Sep; 20(8):1166-1173. PubMed ID: 28964450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life.
    Mitchell J; Wolffsohn JS; Woodcock A; Anderson SJ; McMillan CV; Ffytche T; Rubinstein M; Amoaku W; Bradley C
    Health Qual Life Outcomes; 2005 Apr; 3():25. PubMed ID: 15831093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interviewer Administration Corresponds to Self-Administration of the Vision Impairment in Low Luminance (VILL) Questionnaire.
    Terheyden JH; Mekschrat L; Ost RAD; Bildik G; Berger M; Wintergerst MWM; Holz FG; Finger RP
    Transl Vis Sci Technol; 2022 Apr; 11(4):21. PubMed ID: 35446409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual functioning and quality of life under low luminance: evaluation of the German Low Luminance Questionnaire.
    Finger RP; Fenwick E; Owsley C; Holz FG; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8241-9. PubMed ID: 21908584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF.
    Mukuria C; Rowen D; Brazier JE; Young TA; Nafees B
    Value Health; 2015 Sep; 18(6):846-55. PubMed ID: 26409613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).
    Brazier JE; Rowen D; Mavranezouli I; Tsuchiya A; Young T; Yang Y; Barkham M; Ibbotson R
    Health Technol Assess; 2012 Jul; 16(32):1-114. PubMed ID: 22832015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported utilities in bilateral visual impairment from amblyopia and age-related macular degeneration.
    van de Graaf ES; Despriet DDG; Klaver CCW; Simonsz HJ
    BMC Ophthalmol; 2016 May; 16(1):56. PubMed ID: 27184381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Vision Index: a new method to appraise visual function changes in age-related macular degeneration.
    Piermarocchi S; Varano M; Parravano M; Oddone F; Sartore M; Ferrara R; Sera F; Virgili G
    Eur J Ophthalmol; 2011; 21(1):55-66. PubMed ID: 20640999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparatory study for the revaluation of the EQ-5D tariff: methodology report.
    Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A
    Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the measurement of QALYs in dementia: developing patient- and carer-reported health state classification systems using Rasch analysis.
    Mulhern B; Smith SC; Rowen D; Brazier JE; Knapp M; Lamping DL; Loftus V; Young TA; Howard RJ; Banerjee S
    Value Health; 2012; 15(2):323-33. PubMed ID: 22433764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability, validity and responsiveness of the Greek MacDQoL individualized measure of the impact of macular degeneration on quality of life.
    Marakis TP; Koutsandrea C; Chatzistefanou KI; Tountas Y
    Qual Life Res; 2017 Jan; 26(1):183-191. PubMed ID: 27614659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of health related quality of life and health state utility in patients with age related macular degeneration: the association of contrast sensitivity and visual acuity.
    Bansback N; Czoski-Murray C; Carlton J; Lewis G; Hughes L; Espallargues M; Brand C; Brazier J
    Qual Life Res; 2007 Apr; 16(3):533-43. PubMed ID: 17119846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the content for an item bank and computerized adaptive testing system to measure the impact of age-related macular degeneration on health-related quality of life.
    Fenwick EK; Lee EPX; Man REK; Ho KC; Najjar RP; Milea D; Teo KYC; Tan ACS; Lee SY; Yeo IYS; Tan GSW; Mathur R; Wong TY; Cheung CMG; Lamoureux EL
    Qual Life Res; 2022 Apr; 31(4):1237-1246. PubMed ID: 34562188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.